Scholarlink

<p>Hyperlipidemia is a major modifiable risk factor for atherosclerosis and coronary heart disease. Although effective, current pharmacological interventions such as statins are often limited by adverse effects, including muscular pain, gastrointestinal disturbances, and increased risk of insulin resistance. Consequently, there is a growing interest in exploring safer, natural alternatives that can modulate lipid metabolism with minimal side effects. This study aimed to investigate the synergistic hypolipidemic and antioxidant effects of a combined intervention using bacterial lysates derived from <i>Lactobacillus casei</i> and <i>Lactobacillus acidophilus</i> alongside an extract of <i>Physalis peruviana</i> in a rat model of diet-induced hyperlipidemia. Thirty male Sprague–Dawley rats were randomly assigned to six experimental groups and treated for 7&#xa0;weeks: (1) standard diet (normal control), (2) high-fat diet (HFD, hyperlipidemic control), (3) HFD + <i>Physalis peruviana</i> extract, (4) HFD + bacterial lysate mixture, (5) HFD + <i>Physalis peruviana</i> extract and bacterial lysate mixture, and (6) HFD + atorvastatin (reference drug). Lipid profiles, liver and kidney function markers, and hepatic antioxidant levels were assessed. Histopathological analyses of cardiac and hepatic tissues were also conducted. The combination of bacterial lysates and <i>Physalis peruviana</i> extract significantly reduced (<i>p</i> &lt; 0.05) body weight, total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) while significantly increasing (<i>p</i> &lt; 0.05) high-density lipoprotein (HDL). This treatment also led to notable improvements in hepatic and renal function markers and enhanced hepatic antioxidant activity. Histological examination revealed reduced inflammation in cardiac and hepatic tissues of the combination-treated group, comparable to the effects observed with atorvastatin. The co-administration of <i>Lactobacillus</i> bacterial lysates and <i>Physalis peruviana</i> extract exhibited pronounced hypolipidemic and antioxidant effects, effectively mitigating diet-induced hyperlipidemia and associated organ dysfunction. These findings highlight the potential of this natural therapeutic approach as a functional alternative to conventional lipid-lowering agents in managing hyperlipidemia.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Physalis peruviana and Lactobacillus lysates as modulators of lipid metabolism and oxidative stress: a natural alternative to statin therapy

  • 期刊论文

  • 发表日期：

    2025年10月24日

查看全文
  • Manal Mused Almatrafi,
  • Alaa H. Nada,
  • Ahmed S. Doghish,
  • Dalia Elebeedy,
  • Aml Ghanem,
  • Eman Fayad,
  • Haitham Ibrahim El-Mekkawy,
  • Osama A. Mohammed,
  • Samy Y. Elkhawaga,
  • Dalal Sulaiman Alshaya,
  • Fatimah Hadadi,
  • Ahmad F. Alhomodi,
  • Muhammad Alaa Eldeen,
  • Ahmed I. Abd El Maksoud

摘要

Hyperlipidemia is a major modifiable risk factor for atherosclerosis and coronary heart disease. Although effective, current pharmacological interventions such as statins are often limited by adverse effects, including muscular pain, gastrointestinal disturbances, and increased risk of insulin resistance. Consequently, there is a growing interest in exploring safer, natural alternatives that can modulate lipid metabolism with minimal side effects. This study aimed to investigate the synergistic hypolipidemic and antioxidant effects of a combined intervention using bacterial lysates derived from Lactobacillus casei and Lactobacillus acidophilus alongside an extract of Physalis peruviana in a rat model of diet-induced hyperlipidemia. Thirty male Sprague–Dawley rats were randomly assigned to six experimental groups and treated for 7 weeks: (1) standard diet (normal control), (2) high-fat diet (HFD, hyperlipidemic control), (3) HFD + Physalis peruviana extract, (4) HFD + bacterial lysate mixture, (5) HFD + Physalis peruviana extract and bacterial lysate mixture, and (6) HFD + atorvastatin (reference drug). Lipid profiles, liver and kidney function markers, and hepatic antioxidant levels were assessed. Histopathological analyses of cardiac and hepatic tissues were also conducted. The combination of bacterial lysates and Physalis peruviana extract significantly reduced (p < 0.05) body weight, total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) while significantly increasing (p < 0.05) high-density lipoprotein (HDL). This treatment also led to notable improvements in hepatic and renal function markers and enhanced hepatic antioxidant activity. Histological examination revealed reduced inflammation in cardiac and hepatic tissues of the combination-treated group, comparable to the effects observed with atorvastatin. The co-administration of Lactobacillus bacterial lysates and Physalis peruviana extract exhibited pronounced hypolipidemic and antioxidant effects, effectively mitigating diet-induced hyperlipidemia and associated organ dysfunction. These findings highlight the potential of this natural therapeutic approach as a functional alternative to conventional lipid-lowering agents in managing hyperlipidemia.